MARIMED INC. MRMD revenue by segment, product and geography
In its fiscal year ending 2025-12-31, MARIMED INC. reported revenue across 3 business segments; the largest, Product Sales, was $89M, 55.7% of the filed sum (-2.5% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Reportable Segment-$2.82M100.0%-208.1% yoy
Members sum to the consolidated -$2.82M for this period.
- Product Sales$89M55.7%-2.5% yoy
- Product Sales Wholesale$69.6M43.5%+10.6% yoy
- Other$1.22M0.8%-65.4% yoy
Members sum to the consolidated $160M for this period.
- Product Sales Retail$21.7M55.0%+4.8% yoy
- Product Sales Wholesale$17.5M44.4%+4.4% yoy
- Other Revenue$237K0.6%-39.2% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.